How AI helps you as a pharmacist today
AI handles interaction checks, AMTS documentation, and routine eRezept workflow — the licensed counselling and trust relationship stay yours.
Estimated AI-assistance potential — how much of the work AI tools can take off your plate today.
What AI can do for you
Pharmacy management systems like IXOS (Pharmatechnik), awintaONE (NOVENTI), ADG MS, and ProKas integrate AI modules for interaction and duplicate-prescription checks based on the ABDA database (ABDATA Pharma-Daten-Service). For the eRezept, the system reads the token, reconciles rebate contracts, and proposes the right product. ASK STELLA and similar pharmacy assistants answer standard questions, draft patient leaflets, and support counselling documentation. OTC chatbots (DocMorris, Shop Apotheke) handle self-medication questions around the clock. ChatGPT and Claude help with insurer correspondence and retax appeals; AI tools optimise stock disposition and out-of-stock rates.
What stays in your hands
The pharmacy licence (Approbation), dispensing of prescription drugs, and final responsibility for counselling stay legally protected — PharmBetrO § 20 requires information and counselling under licensed staff. Complex drug-safety cases (polymedication in multimorbid patients, anticoagulant interactions, pregnancy, paediatrics, oncology), narcotic prescription plausibility checks, compounding (galenics), on-call duty, and acute triage at the counter are licence-protected. Reimbursed pharmaceutical services (medication review, hypertension screening, inhaler training) explicitly cannot be delivered telepharmaceutically — they require structured counselling on the premises.
Where the role is heading
The role is shifting, not disappearing. The number of pharmacies dropped to 16,601 by end of 2025 — 502 closures vs 62 openings, the lowest level in nearly 50 years (ABDA). Drivers: stagnant fixed compensation since 2013 against 65 % cost inflation, mail-order competition (Shop Apotheke is the 2025 mail-order Rx market leader with around half a billion euros Rx revenue, DocMorris in second place), and the eRezept rollout since the 2024 GKV mandate. The market for reimbursed services (since 2022) is growing, and the 2026 reform opens further ground. Those focusing on counselling, medication reviews, and chronic patients are safe. Those handing out packages lose to mail order. Licensed activities stay — the question is in which setting (community, hospital, industry, regulatory).
How to start using AI today
Sharpen your profile as a counselling pharmacist. (1) Certifications for the reimbursed services through state chambers (BLAK, AKBerlin) — most direct revenue lever. (2) Deepen drug-safety, clinical pharmacy, a specialist area (oncology, geriatrics, paediatrics, nursing-home care). (3) Master your management system (IXOS, awintaONE, ADG MS) as a power user including eRezept workflow, retax avoidance, AI modules. (4) Hospital pharmacy (Approbation plus specialist training), pharma industry (Medical Affairs, Pharmacovigilance), or regulatory (BfArM, state authorities) are alternative tracks — the licensed pharmacist is broadly employable.
Concrete ways AI helps in your daily work
eRezept workflow without paper breaks
Since 1 January 2024 the eRezept is mandatory for GKV prescriptions; in 2026 the system runs on version 1.3.0 (PZN and active-substance prescriptions tied to certified prescribing software). The management system (IXOS, awintaONE, ADG MS) pulls the prescription via token, eGK, or app, reconciles rebate contracts, and proposes the product. What used to be reading handwritten scripts and typing PZN is now automatic — the pharmacist checks plausibility, interactions, supply, and signs off. Saves about a minute per prescription — roughly half a PTA shift per day in a mid-sized pharmacy.
Drug-safety check: interactions, duplicates, contraindications
Modern pharmacy software runs ABDA checks automatically when a prescription is read in and flags hits in colour-coded tiers. Polymedication of eight or more substances — typical for geriatric patients — often produces 5-10 hits to review, formerly looked up manually. The licensed pharmacist now sees a prioritised list, clarifies the relevant points with the prescriber, and documents the counselling — the core service AI accelerates rather than replaces.
Reimbursed pharmaceutical services as a revenue pillar
Since 2022 five reimbursed services exist — medication review type 2a (€90), pharmaceutical care for polymedication (€90/year), standardised hypertension risk screening (€11.20), inhaler training (€20), extended medication counselling after organ transplant (€90). Software modules (IXOS PHARMA-DL, awinta DL module) guide the pharmacist through the structured documentation. Two to three medication reviews a week generate additional revenue in the low five-figure range annually — the lever independent pharmacies use to offset Rx-margin erosion.
Patient education and dosing instructions with AI support
ChatGPT, Claude, and ASK STELLA draft understandable patient leaflets from bullet points — dosing schemes, side-effect notes, instructions for inhalers, insulin pens, eye drops. Particularly valuable for multilingual patients or those with low vision (18 pt print, plain language). Important: the pharmacist reviews, adds patient-specific notes (food interactions, exercise, daily rhythm), and signs — responsibility stays with the licensed person, AI is the pen, not the brain.
Stock and out-of-stock disposition with forecasting
Pharmacy software uses sales history and seasonality to optimise reordering. IXOS, awintaONE, and ADG MS ship forecasting modules. Cold-wave forecasts from weather and RKI data, on-call cycles, and cross-branch stock balancing drop typical 8-12 % out-of-stock rates to 3-5 %. Matters commercially — and frees PTAs from endless backorder chasing.
Retax avoidance and insurer correspondence
Statutory insurers retax pharmacies annually in the low single-digit percent of Rx revenue — formal errors, wrong PZN, rebate-contract deviations, missing markers. Modern systems check every prescription against rebate contracts before billing; AI modules suggest appeal texts. ChatGPT helps phrase retax appeals — pharmacists check legal references to § 129 SGB V framework agreements and submit. Often saves several thousand euros per year in mid-sized pharmacies.
Online competition: hybrid strategy instead of displacement
Shop Apotheke and DocMorris dominate the mail-order Rx segment in Germany — Shop Apotheke is the 2025 mail-order Rx leader, DocMorris in second; mail-order overall still holds only a few percent of the entire German Rx market. Local response: same-day courier, click & collect, branded pharmacy app with eRezept integration, personal home delivery. Software vendors build these modules in (IXOS Botendienst, awinta TouchToGo). Orchestrated well, this wins back chronic and elderly patients — personal counselling plus delivery convenience often beats anonymous mail-order discounts.
AI tools worth a look
IXOS (Pharmatechnik)
Software service from ~€12.50 per workstation per month, system licences and hardware in the four- to five-figure range depending on pharmacy size — typical total cost in the low five-figure range per year for a mid-sized pharmacy
Market-leading pharmacy software in Germany, deeply integrated with eRezept, ABDATA interaction checks, reimbursed services, courier delivery, and chain operations. Industry standard with broad feature set and an established training ecosystem.
awintaONE / ProKas (NOVENTI / awinta GmbH)
Licence- and module-based — typical rental from ~€250-500/month for a single pharmacy, multi-branch packages higher
Modern, cloud-capable pharmacy management system, multi-branch ready, with eRezept module, drug-safety check, reimbursed-services module, and integrated interfaces for delivery and e-commerce. ProKas is the standard POS component.
ADG MS (PHOENIX group)
Contract-based, often bundled with PHOENIX wholesale terms — direct list prices on request
Established management system from the PHOENIX group, strong in pharmacies close to wholesale and in chains. eRezept integration, ABDATA, reimbursed-services module, interfaces to ordering and logistics systems.
ABDATA Pharma-Daten-Service / ABDA database
Licence usually bundled with the management system — direct ABDATA licences from ~€200/month per module
Clinical backbone in every German pharmacy — interaction check, contraindications, dosing, drug substance database. New AI modules build directly on it.
Gematik telematics infrastructure (TI) + eRezept app
Partly reimbursed via GKV TI funding — connector €2,000-4,000 one-off, monthly fees per contract
Mandatory backbone for eRezept, eAU, ePA, KIM mail. TI connectors (Apotheke vor Ort 1A) provide access. The federal eRezept app addresses patients; the pharmacy sees the token in its system.
ASK STELLA (pilot)
Pilot phase, official launch announced for 2026 — pricing TBD
Pharmacy-specific AI assistant answering questions from professional knowledge bases and ABDATA. Next-generation counselling AI — framed as support for licensed staff, not a replacement.
ChatGPT / Claude for back-office correspondence
Free up to ~€20-30/month — Microsoft Copilot for Microsoft 365 from ~€22/user/month
All-rounder for retax appeals, patient leaflets, scheduling, marketing copy. Caution: no patient data in public LLMs — use GDPR-compliant solutions (Microsoft Copilot, Claude for Work) for sensitive data.
Independent overview — prices as of today and subject to change. No paid placement.
Frequently asked questions
Will I be replaced as a community pharmacist in the next few years?+
Directly replaced, no — the Approbation requirement and PharmBetrO § 20 keep counselling tied to licensed staff. But the market gets harder: pharmacy attrition (16,601 left by end of 2025, lowest level in nearly 50 years per ABDA), Shop Apotheke is the 2025 mail-order Rx leader ahead of DocMorris (together a few percent of the entire German Rx market), eRezept accelerating mail-order convenience. Pharmacies focused on counselling, reimbursed services, and chronic patients are safe. Those mostly handing out packages feel margin pressure first. Picture: fewer pharmacies, more counselling output per pharmacy — the licensed profession overall stable.
How does the eRezept work in practice in 2026?+
The patient receives a token printout, loads the eRezept into the federal app, or has it on the eGK. The management system reads it, reconciles with the rebate contract, and proposes the product. Since version 1.3.0 (October 2025), PZN and active-substance prescriptions are tied to certified prescribing software. 2026 reality: eRezept is standard, paper prescriptions are exceptions. The pharmacist remains responsible for plausibility, drug-safety, prescriber callbacks — routine typing and rebate reconciliation are gone.
Are reimbursed pharmaceutical services really worth it?+
Yes — consistent delivery generates meaningful additional revenue. Five services with fees from €11.20 (hypertension risk screening) to €90 (medication review type 2a, polymedication care, extended counselling after organ transplant). Importantly, they cannot be delivered telepharmaceutically — they require structured counselling on the premises, the protective fence against mail-order competition. Prerequisites: courses through state pharmacy chambers (BLAK, AKBerlin etc.) and a software module handling insurer documentation. Realistic: 2-3 medication reviews per week lift pharmacy revenue into the low five-figure range per year.
What do I need to know about AI advice apps and online-pharmacy chatbots?+
Three things matter. First: AI apps (ChatGPT, ASK STELLA, DocMorris chatbot) handle standard self-medication questions reasonably well — patients arrive better informed. Second: AI does not replace rule-based drug-safety checks or complex pharmacological decisions, and the ABDA emphasises this. Third: your role shifts from first-line informant to validator — the patient has researched, you check whether it's right, add patient-specific aspects (renal function, comedication, pregnancy), and take responsibility. More demanding than pure information delivery, but also more valuable — a real differentiator versus mail-order and apps.
Community pharmacy, hospital pharmacy, industry, or regulatory — where is the career stable?+
All four paths persist with different profiles. Community: stable when focused on counselling and services. Hospital pharmacy (specialist training in clinical pharmacy): growing because drug-safety and antibiotic stewardship become mandatory. Pharma industry (Medical Affairs, Pharmacovigilance, Regulatory Affairs): higher salaries, eRezept and digital health drive demand. Regulatory (BfArM, PEI, state authorities): predictable career, public pay scale. Rule of thumb: the Approbation opens all four doors, the right add-on qualification decides.
Which continuing-education paths are worth pursuing in the next 2-3 years?+
Four recommendations depending on setting. First: certifications for the reimbursed services through the state chamber — direct revenue lever, 1-3 days per curriculum. Second: specialist pharmacist training (general, clinical, oncology, geriatric pharmacy) — structured 3-year programme, strong differentiator. Third: power-user training for your management system including eRezept and AI modules — low cost, big lift in operational efficiency. Fourth: drug-safety / polymedication deep-dive via DGKPha or ABDA Academy. For industry or regulatory: GxP, pharmacovigilance, or regulatory-affairs courses.
Looking from the other side?
If you want to understand whether AI puts your role at risk — without panic, but honestly — our sister site kineangst.de/jobs/pharmazeut runs the same profession through a risk-assessment lens.
Looking for ready-made tools that save time? On serahr.de we offer a few solutions — for example a website FAQ chatbot or a monitoring service for legal compliance changes.